article thumbnail

Supercharging AI-drug discovery with strategic multiomic biobanks 

Drug Discovery World

Narain , PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market. Not all biobanks are created equal Biobanks provide a treasure trove of clinical data for exploration with AI tools. But the utility of biobanks varies.

article thumbnail

Drug discovery hotspots: Focus on Qatar

Drug Discovery World

DDW Editor Reece Armstrong takes a look at Qatar’s drug discovery and life sciences market, exploring how the country is utilising innovative technologies in its approach to healthcare. The Middle East represents one of the world’s most lucrative markets for pharmaceuticals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digitalising drug discovery

pharmaphorum

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

article thumbnail

The post-Covid New Normal: a golden opportunity for the NHS?

pharmaphorum

I recently had the pleasure of attending the PING Conference 2022 , which had the tagline of ‘The Golden Age for Life Sciences Innovation’. Aspirations for the UK in life sciences. So, with all that said, are we really in a golden age for UK life sciences? Reducing complexity across the NHS.

article thumbnail

New Research Reveals How Air Pollution May Trigger Lung Cancer

XTalks

They performed ultra-deep genomic profiling of normal lung tissue samples and tissues exposed to PM (both human and mouse tissues) and examined the effects of the PM on tumor promotion in mouse lung cancer models. The researchers performed a combination of human and animal experiments to examine a potential link between PM 2.5

article thumbnail

Biorepositories as a Guiding Resource for Research & Drug Discovery

XTalks

The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Biobanks are used for the coordination of high-yield patient sample collection. Generation of strong research dataset cohorts must begin with high-quality clinical samples.

article thumbnail

Bayer to present latest research across its advancing oncology portfolio at AACR 2023 Annual Meeting

The Pharma Data

About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. The company’s approach to research prioritizes targets and pathways with the potential to impact the way that cancer is treated.